Evidence map›Paper›PMID 37027101›Full record

ArticleSurgical case reports2023

Retiform hemangioendothelioma of the breast in a man with

Kaoru Ogura, Yoko Shibasaki, Satoshi Honda, Hidetaka Akita, Nobuhiko Aoki, Ja-Mun Chong, Toru Motoi

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Surgical case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Kaoru OguraDepartment of Breast Surgery, Tokyo Metropolitan Toshima Hospital, 33-1 Sakae-Cho, Itabashi-Ku, Tokyo, 173-0015, Japan. kdomoto@hotmail.com.ORCID http://orcid.org/0000-0002-1213-1337
Yoko ShibasakiDepartment of Pathology, Tokyo Metropolitan Toshima Hospital, 33-1 Sakae-Cho, Itabashi-Ku, Tokyo, 173-0015, Japan.
Satoshi HondaDepartment of Radiology, Tokyo Metropolitan Toshima Hospital, 33-1 Sakae-Cho, Itabashi-Ku, Tokyo, 173-0015, Japan.
Hidetaka AkitaDepartment of Pathology, Tokyo Metropolitan Toshima Hospital, 33-1 Sakae-Cho, Itabashi-Ku, Tokyo, 173-0015, Japan.
Nobuhiko AokiDepartment of Breast Surgery, Tokyo Metropolitan Toshima Hospital, 33-1 Sakae-Cho, Itabashi-Ku, Tokyo, 173-0015, Japan.
Ja-Mun ChongDepartment of Pathology, Tokyo Metropolitan Toshima Hospital, 33-1 Sakae-Cho, Itabashi-Ku, Tokyo, 173-0015, Japan.
Toru MotoiDepartment of Pathology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.
Toshima Hospital · JPTokyo Metropolitan Geriatric Hospital · JPTokyo Metropolitan Komagome Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRetiform hemangioendothelioma (RH) is a rare, intermediate-grade vascular tumor that often arises in the trunk and extremities. The clinical and radiological features of RH remain largely unknown. CASE PRESENTATION: A male patient in his 70s presented with shortness of breath on exertion, and computed tomography incidentally revealed a tumor in his right breast. Positron emission tomography (PET) revealed moderate

conclusionsRH was found in the male breast and was accompanied by FDG uptake on PET. PET may be useful in diagnosing RH. Although metastasis is rare in RH, local recurrence may occur, and careful follow-up is required.

Indexed as

AngiosarcomaBreastMagnetic resonance imagingMalePositron emission tomographyRetiform hemangioendothelioma

Identifiers

PMID37027101
PMCPMC10082138
OpenAlexW4362692655

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.